Metropolitan Life Insurance Co. NY increased its stake in Genesco Inc. (NYSE:GCO) by 359.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,689 shares of the company’s stock after purchasing an additional 5,233 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Genesco were worth $296,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GCO. BlackRock Inc. boosted its stake in shares of Genesco by 3.6% during the 4th quarter. BlackRock Inc. now owns 2,944,051 shares of the company’s stock worth $130,421,000 after buying an additional 103,596 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Genesco by 2.2% during the 3rd quarter. Vanguard Group Inc. now owns 1,920,730 shares of the company’s stock worth $90,466,000 after buying an additional 41,294 shares during the last quarter. Vanguard Group Inc boosted its stake in shares of Genesco by 2.2% during the 3rd quarter. Vanguard Group Inc now owns 1,920,730 shares of the company’s stock worth $90,466,000 after buying an additional 41,294 shares during the last quarter. FMR LLC boosted its stake in shares of Genesco by 9.3% during the 3rd quarter. FMR LLC now owns 1,122,800 shares of the company’s stock worth $52,884,000 after buying an additional 95,644 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in shares of Genesco by 99.7% during the 4th quarter. Canada Pension Plan Investment Board now owns 595,200 shares of the company’s stock worth $26,365,000 after buying an additional 297,144 shares during the last quarter.

In related news, Director Marty G. Dickens sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, January 29th. The shares were sold at an average price of $49.50, for a total value of $247,500.00. Following the completion of the sale, the director now directly owns 18,578 shares in the company, valued at approximately $919,611. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Robert J. Dennis sold 11,380 shares of the firm’s stock in a transaction dated Wednesday, January 23rd. The shares were sold at an average price of $47.14, for a total transaction of $536,453.20. Following the completion of the sale, the chief executive officer now owns 261,361 shares of the company’s stock, valued at $12,320,557.54. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

A number of equities analysts have recently commented on GCO shares. Pivotal Research set a $52.00 price objective on shares of Genesco and gave the stock a “buy” rating in a research note on Monday, December 17th. TheStreet upgraded shares of Genesco from a “c+” rating to a “b” rating in a research note on Tuesday, January 8th. Zacks Investment Research upgraded shares of Genesco from a “hold” rating to a “strong-buy” rating and set a $55.00 price objective for the company in a research note on Saturday, January 19th. Finally, ValuEngine downgraded shares of Genesco from a “buy” rating to a “hold” rating in a research note on Friday, March 1st. One analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. Genesco has a consensus rating of “Hold” and an average price target of $44.00.

Genesco stock opened at $43.92 on Thursday. Genesco Inc. has a one year low of $37.00 and a one year high of $51.85. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.65 and a quick ratio of 1.32. The stock has a market cap of $791.20 million, a PE ratio of 13.39, a price-to-earnings-growth ratio of 2.46 and a beta of 0.71.

Genesco (NYSE:GCO) last posted its quarterly earnings data on Thursday, March 14th. The company reported $2.18 EPS for the quarter, missing the Zacks’ consensus estimate of $2.30 by ($0.12). Genesco had a positive return on equity of 7.52% and a negative net margin of 1.93%. The business had revenue of $675.50 million for the quarter, compared to analyst estimates of $914.85 million. During the same quarter in the prior year, the company earned $2.15 earnings per share. The company’s quarterly revenue was down 2.0% on a year-over-year basis. On average, sell-side analysts expect that Genesco Inc. will post 3.5 earnings per share for the current fiscal year.

Genesco announced that its Board of Directors has initiated a stock buyback plan on Friday, December 14th that permits the company to repurchase $125.00 million in shares. This repurchase authorization permits the company to purchase up to 14.7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/genesco-inc-gco-shares-bought-by-metropolitan-life-insurance-co-ny/2954924.html.

About Genesco

Genesco Inc retails and wholesales footwear, apparel, and accessories. The company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, Shi by Journeys, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children.

Read More: Why do corrections happen?

Want to see what other hedge funds are holding GCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genesco Inc. (NYSE:GCO).

Institutional Ownership by Quarter for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.